0001372514-24-000088.txt : 20240703
0001372514-24-000088.hdr.sgml : 20240703
20240703151515
ACCESSION NUMBER: 0001372514-24-000088
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240701
FILED AS OF DATE: 20240703
DATE AS OF CHANGE: 20240703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: TYLE PRAVEEN
CENTRAL INDEX KEY: 0001296936
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36672
FILM NUMBER: 241099795
MAIL ADDRESS:
STREET 1: ONE BAUSCH & LOMB PLACE
CITY: ROCHESTER
STATE: NY
ZIP: 14604
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: KIORA PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001372514
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 332 ENCINITAS BOULEVARD
STREET 2: SUITE 102
CITY: ENCINITAS
STATE: CA
ZIP: 92024
BUSINESS PHONE: 781-788-8869
MAIL ADDRESS:
STREET 1: 332 ENCINITAS BOULEVARD
STREET 2: SUITE 102
CITY: ENCINITAS
STATE: CA
ZIP: 92024
FORMER COMPANY:
FORMER CONFORMED NAME: EYEGATE PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20060811
4
1
wk-form4_1720034108.xml
FORM 4
X0508
4
2024-07-01
0
0001372514
KIORA PHARMACEUTICALS INC
KPRX
0001296936
TYLE PRAVEEN
C/O KIORA PHARMACEUTICALS, INC.
332 ENCINITAS BLVD., SUITE 102
ENCINITAS
CA
92024
1
0
0
0
0
Stock Option (right to buy)
4.35
2024-07-01
4
A
0
1778
0
A
2025-07-01
2034-07-01
Common Stock
1778
1778
D
The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2024 Equity Incentive Plan. The Option will become fully exercisable on July 1, 2025.
/s/ Melissa Tosca, Attorney-in-Fact
2024-07-03